CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Louisville, Kentucky, United States and 5 other locations
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...
Phase 2
Louisville, Kentucky, United States and 16 other locations
A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...
Phase 2
Louisville, Kentucky, United States and 7 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Louisville, Kentucky, United States and 135 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Louisville, Kentucky, United States and 24 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...
Phase 2
Louisville, Kentucky, United States and 71 other locations
The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer...
Phase 2
Louisville, Kentucky, United States and 8 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
Louisville, Kentucky, United States and 48 other locations
This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for ...
Phase 2
Louisville, Kentucky, United States and 65 other locations
This study is open to adults with advanced solid tumors whose previous cancer treatment was not successful. People can participate ...
Phase 1
Louisville, Kentucky, United States and 13 other locations
Clinical trials
Research sites
Resources
Legal